|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/07 | |
| A61K 9/08 | |||
| A61P 25/00 | |||
| A61K 47/02 | |||
| A61K 47/18 |
| (11) | Number of the document | 3134103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15783438.3 |
| Date of filing the European patent application | 2015-04-27 | |
| (97) | Date of publication of the European application | 2017-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/027745 |
| Date | 2015-04-27 |
| (87) | Number | WO 2015/164859 |
| Date | 2015-10-29 |
| (30) | Number | Date | Country code |
| 201461984216 P | 2014-04-25 | US |
| (72) |
HOUCK, David, Renwick, US
ARGHAVANI, Mohsen, US
|
| (73) |
Naurex Inc.,
1801 Maple Avenue, Suite 4300, Evanston, Illinois 60201,
US
|
| (54) | STABLE COMPOSITIONS OF NEUROACTIVE PEPTIDES |
| STABLE COMPOSITIONS OF NEUROACTIVE PEPTIDES |